Literature DB >> 17682124

Human BSAP and BLIMP1 conform an autoregulatory feedback loop.

Francisco Mora-López1, Elena Reales, José A Brieva, Antonio Campos-Caro.   

Abstract

B-lymphocyte-induced maturation protein-1 (BLIMP1), encoded by the PRDM1 gene, is a transcriptional repressor considered a master regulator that is required and sufficient for plasma cell (PC) differentiation. BLIMP1 represses the PAX5 gene, coding for the B-cell lineage-specific activator protein (BSAP), which is required for B-cell identity and survival. Mutations in PAX5 gene as well as in PRDM1 gene have been recently implicated in lymphomas. In the present study, sequence analysis of PRDM1 gene revealed a binding site for BSAP transcription factor. By analyzing different human cell lines, we have found that a specific nuclear factor for B-cell lines binds to a site on the PRDM1 promoter. Electrophoretic mobility shift assays identified this factor as BSAP, and chromatin immunoprecipitation assays confirmed its binding in vivo to the human PRDM1 promoter. Moreover, by ectopically expressing BSAP, and using a PRDM1 promoter with the BSAP-binding site mutated, we demonstrated that this factor represses the expression of BLIMP1. Therefore, repression of PRDM1 by BSAP reveals an autoregulatory negative-feedback loop that could play a relevant role in controlling human PC differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17682124     DOI: 10.1182/blood-2007-05-092262

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

1.  Quantitative modeling of the terminal differentiation of B cells and mechanisms of lymphomagenesis.

Authors:  María Rodríguez Martínez; Alberto Corradin; Ulf Klein; Mariano Javier Álvarez; Gianna M Toffolo; Barbara di Camillo; Andrea Califano; Gustavo A Stolovitzky
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma.

Authors:  Jonathan Mandelbaum; Govind Bhagat; Hongyan Tang; Tongwei Mo; Manisha Brahmachary; Qiong Shen; Amy Chadburn; Klaus Rajewsky; Alexander Tarakhovsky; Laura Pasqualucci; Riccardo Dalla-Favera
Journal:  Cancer Cell       Date:  2010-12-14       Impact factor: 31.743

Review 3.  The long winding road toward understanding the molecular mechanisms for B-cell suppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  Courtney E W Sulentic; Norbert E Kaminski
Journal:  Toxicol Sci       Date:  2010-10-15       Impact factor: 4.849

4.  A bistable switch underlying B-cell differentiation and its disruption by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  Sudin Bhattacharya; Rory B Conolly; Norbert E Kaminski; Russell S Thomas; Melvin E Andersen; Qiang Zhang
Journal:  Toxicol Sci       Date:  2010-02-01       Impact factor: 4.849

5.  Attenuation of antigenic immunogenicity by kynurenine, a novel suppressive adjuvant.

Authors:  Zhiqing Duan; Yunqing Duan; Huangui Lei; Ningzhu Hu; Jiandong Shi; Dong Shen; Xi Wang; Yunzhang Hu
Journal:  Hum Vaccin Immunother       Date:  2014-02-28       Impact factor: 3.452

6.  Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.

Authors:  Dina Schneider; Maria A Manzan; Byung Sun Yoo; Robert B Crawford; Norbert Kaminski
Journal:  Toxicol Sci       Date:  2009-02-23       Impact factor: 4.849

Review 7.  New insights into the regulation of human B-cell differentiation.

Authors:  Heike Schmidlin; Sean A Diehl; Bianca Blom
Journal:  Trends Immunol       Date:  2009-05-15       Impact factor: 16.687

8.  Stochastic modeling of B lymphocyte terminal differentiation and its suppression by dioxin.

Authors:  Qiang Zhang; Sudin Bhattacharya; Douglas E Kline; Robert B Crawford; Rory B Conolly; Russell S Thomas; Norbert E Kaminski; Melvin E Andersen
Journal:  BMC Syst Biol       Date:  2010-04-01

9.  All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  Qiang Zhang; Douglas E Kline; Sudin Bhattacharya; Robert B Crawford; Rory B Conolly; Russell S Thomas; Melvin E Andersen; Norbert E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  2013-01-26       Impact factor: 4.219

10.  Blimp-1/Prdm1 alternative promoter usage during mouse development and plasma cell differentiation.

Authors:  Marc A J Morgan; Erna Magnusdottir; Tracy C Kuo; Chai Tunyaplin; James Harper; Sebastian J Arnold; Kathryn Calame; Elizabeth J Robertson; Elizabeth K Bikoff
Journal:  Mol Cell Biol       Date:  2009-09-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.